Home > Balance Sheet > GLENMARK PHARMACEUTICALS

GLENMARK PHARMACEUTICALS
Contingent Liabilities

    Back to Balance Sheet
GLENMARK PHARMACEUTICALS is part of below Screeners ↓
Best 1M Momentum Mid Cap Stocks
COMMUNITY POLL
for GLENMARK PHARMACEUTICALS
Please provide your vote to see the results

GLENMARK PHARMACEUTICALS Last 5 Year Contingent Liabilities History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
Contingent Liabilities ₹1,063 Cr₹337 Cr₹361 Cr₹384 Cr₹271 Cr

What is the latest Contingent Liabilities ratio of GLENMARK PHARMACEUTICALS ?

The latest Contingent Liabilities ratio of GLENMARK PHARMACEUTICALS is ₹1,063 Cr based on Mar2024 Consolidated results.
Year Contingent Liabilities
Mar2024₹1,063 Cr
Mar2023₹337 Cr
Mar2022₹361 Cr
Mar2021₹384 Cr
Mar2020₹271 Cr

How is Contingent Liabilities of GLENMARK PHARMACEUTICALS Trending?

Years Contingent Liabilities % Change
Mar2024 ₹1,063 Cr
215.81
Mar2023 ₹337 Cr
-6.81
Mar2022 ₹361 Cr
-5.96
Mar2021 ₹384 Cr
41.66
Mar2020 ₹271 Cr -

Compare Contingent Liabilities of peers of GLENMARK PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS ₹62,844.5 Cr 21.3% 32.9% 58.2% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹414,533.0 Cr 0.6% -0.4% 4.7% Stock Analytics
DIVIS LABORATORIES ₹180,215.0 Cr -2.2% 1.7% 47.3% Stock Analytics
CIPLA ₹120,428.0 Cr -0.2% -1.4% -1.9% Stock Analytics
TORRENT PHARMACEUTICALS ₹116,410.0 Cr 2.5% 4.8% 12.2% Stock Analytics
DR REDDYS LABORATORIES ₹105,253.0 Cr -2.6% -8.1% -4.9% Stock Analytics


GLENMARK PHARMACEUTICALS Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS

21.3%

32.9%

58.2%

SENSEX

-1.4%

1.8%

3.3%


You may also like the below Video Courses